Epigallocatechin-3-gallate (EGCG) is a polyphenolic compound found in green tea and is commonly studied for its antioxidant properties. Experimental research has examined EGCG in relation to beta-amyloid, a peptide associated with Alzheimer’s disease pathology. In animal models, EGCG has been reported to influence beta-amyloid deposition and memory-related outcomes.
Research published in Neuroscience Letters (2010; 471(3):134–138) examined the effects of EGCG and fish oil in a mouse model genetically engineered to develop Alzheimer’s-like pathology. The mice were divided into five groups and fed different diets for six months: a standard control diet, fish oil alone, a high dose of EGCG, a low dose of EGCG, or a low dose of EGCG combined with fish oil.
The investigators reported that mice receiving the combination of EGCG and fish oil showed a reduction in amyloid plaque deposition compared with controls. Low-dose EGCG alone did not produce the same effect. Higher concentrations of EGCG were detected in both blood and brain tissue in mice receiving EGCG together with fish oil. The authors proposed that fish oil may have enhanced the bioavailability of EGCG in this model.
These findings reflect preclinical research exploring interactions between dietary polyphenols and lipids in neurodegenerative disease models and were not intended to establish clinical relevance in humans.
